Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Baniecki, MaryLynn, Hendrick, Victoria M, Damle, Bharat, Simón-Campos, Abraham, Pypstra, Rienk, Rusnak, James M
Published in New England Journal of Medicine (14.04.2022)
Published in New England Journal of Medicine (14.04.2022)
Get full text
Journal Article
Web Resource
The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
Chan, Phylinda L.S., McFadyen, Lynn, Quaye, Andrea, Leister‐Tebbe, Heidi, Hendrick, Victoria M., Hammond, Jennifer, Raber, Susan
Published in CPT: pharmacometrics and systems pharmacology (01.06.2021)
Published in CPT: pharmacometrics and systems pharmacology (01.06.2021)
Get full text
Journal Article
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Hammond, Jennifer, Fountaine, Robert J., Yunis, Carla, Fleishaker, Dona, Almas, Mary, Bao, Weihang, Wisemandle, Wayne, Baniecki, Mary Lynn, Hendrick, Victoria M., Kalfov, Veselin, Simón-Campos, J. Abraham, Pypstra, Rienk, Rusnak, James M.
Published in The New England journal of medicine (04.04.2024)
Published in The New England journal of medicine (04.04.2024)
Get full text
Journal Article
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis
Bradley, John S, Stone, Gregory G, Chan, Phylinda L S, Raber, Susan R, Riccobene, Todd, Mas Casullo, Veronica, Yan, Jean Li, Hendrick, Victoria M, Hammond, Jennifer, Leister-Tebbe, Heidi K
Published in The Pediatric infectious disease journal (01.05.2020)
Published in The Pediatric infectious disease journal (01.05.2020)
Get more information
Journal Article